Patent · US Expired

Tricyclic thromboxane A.sub.2 antagonists

US5143922A · kind A · utility

19Cited by
7References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 20, 1990
Grant dateSep 1, 1992
Priority date
Expiry dateNov 20, 2010

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel tricyclic compounds having a TXA.sub.2 antagonizing activity represented by formula (I): ##STR1## possess a potent antagonizing action against thromboxane A.sub.2 and also an antiallergic and/or antihistaminic acitvity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.